Targeting P2X7 mitigates neurobehavioural alterations in a mouse model of post-acute sequelae of SARS-CoV-2 infection

Szabó, Dorottya [Szabó, Dorottya (neurofarmakológia), author] Laboratory of Molecular Pharmacology; School of PhD Studies (SU); Tod, Pál* [Tod, Pál (Purinerg jelátvit...), author] Laboratory of Molecular Pharmacology; Maácz, Fruzsina [Maácz, Fruzsina (Neurofarmakológia), author] Laboratory of Molecular Pharmacology; School of PhD Studies (SU); Gölöncsér, Flóra [Gölöncsér, Flóra (idegtudományok), author] Laboratory of Molecular Pharmacology; Iring-Varga, Bernadett [Iring-Varga, Bernadett (funkcionális ideg...), author] Laboratory of Molecular Pharmacology; School of PhD Studies (SU); Török, Bibiána [Szocsics-Török, Bibiána (Biológus), author] Laboratory of Molecular Pharmacology; Zsidei, Gyula; Pályi, Bernadett [Pályi, Bernadett (virológia), author] National Center for Public Health and Pharmacy; Kis, Zoltán [Kis, Zoltán (Mikrobiológia, Vi...), author] National Center for Public Health and Pharmacy; Sperlágh, Beáta ✉ [Sperlágh, Beáta (Neurofarmakológia), author] Laboratory of Molecular Pharmacology; School of PhD Studies (SU)

Fundings:

• Hungarian Brain Research Program(NAP2022-I-1/2022)
• Recovery and Resilience Facility of the European Union within the framework of Programme Szécheny...(RRF-2.3.1-21-2022-00011)
• Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015) Funder: NRDIO
• National Laboratory of Translational Neuroscience (TINL)(RRF-2.3.1-21-2022-00011)